Rituximab and Belimumab Combination Therapy in PR3 Vasculitis
Phase 2
- Conditions
- ANCA Associated VasculitisGranulomatosis With Polyangiitis
- Interventions
- First Posted Date
- 2019-05-30
- Last Posted Date
- 2022-03-08
- Lead Sponsor
- Rachel Jones
- Target Recruit Count
- 31
- Registration Number
- NCT03967925
- Locations
- π¬π§
Addenbrooke's Hospital, Cambridge, United Kingdom
π¬π§Glasgow Royal Infirmary, Glasgow, United Kingdom
π¬π§Imperial College London, London, United Kingdom
Β© Copyright 2025. All Rights Reserved by MedPath